# Attovia Therapeutics, Inc. (ATTO)

> Healthcare · US

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ATTO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 1.19B | $ -90.68M | $ -42.76M | $ 715.56M | $ -164.08M |
| 2021 | $ 1.72B | $ -107.34M | $ -7.41M | $ 718.28M | $ -10.19M |
| 2020 | $ 1.80B | $ -59.56M | $ 114.76M | $ 726.58M | $ 119.09M |
| 2019 | $ 2.20B | $ -104.78M | $ 7.59M | $ 720.61M | $ 207.02M |
| 2018 | $ 2.40B | $ 24.55M | $ 44.72M | $ 459.77M | $ 331.55M |
| 2017 | $ 2.59B | $ -22.64M | $ 50.64M | $ 486.29M | $ 361.02M |
| 2016 | $ 2.42B | $ 89.4K | $ 100.39M | $ 534.94M | $ 430.93M |
| 2015 | $ 2.76B | $ 69.01M | $ -83.65M | $ 575.57M | $ 397.79M |
| 2014 | $ 3.25B | $ -59.56M | $ 24.48M | $ 653.31M | $ 464.87M |
| 2013 | $ 3.33B | $ -11.64M | $ -5.70M | $ 851.11M | $ -133.97M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -4.36 |
| Liabilities / Eq | -7.05 |
| Current Ratio | 0.95 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / FCF | 38.70 |

## Other views

- [Metrics](https://sponda.capital/en/ATTO.md)
- [Charts](https://sponda.capital/en/ATTO/charts.md)
- [Compare](https://sponda.capital/en/ATTO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.